Adaptimmune Presents Safety Data with Evidence of Tumor Necrosis in One Patient from ADP-A2AFP Study at American Association for Cancer Research (AACR) Meeting April 2, 2019
Precision BioSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares April 1, 2019
Adaptimmune Presents Preclinical Data for its Next Generation SPEAR T-cell Targeting MAGE-A4 at the American Association for Cancer Research (AACR) Annual Meeting April 1, 2019
Orchard Therapeutic’s Gene Therapy Exceeds Expectations in Treating Children’s Neurological Disease March 28, 2019
Lewis And Clark Information Exchange Announces Partnership with PatientPing to Advance Care Coordination Efforts Across the Midwest March 27, 2019
Ultragenyx Announces Approval of Crysvita® (burosumab) in Brazil for the Treatment of X-linked Hypophosphatemia (XLH) in Adults and Children March 26, 2019